Uncovering Answers to Protect Patients' Health
Boehringer Ingelheim has a large and experienced global team managing and conducting clinical trials in many indications. During the past decade from 200 to 2009, Boehringer Ingelheim conducted or sponsored 1,296 studies with 112 substances in 84 countries from all regions of the world.
Basic Information
Boehringer Ingelheim conducts and sponsors clinical trials to establish safety and efficacy of the drugs we develop, either for use in their initial indication or in additional indications.
